抗抑郁药与肺炎和COPD患者的恶化之间的关联:一个自我控制的病例系列 (SCCS)
Rayan A Siraj1,2, Charlotte E Bolton2, Tricia M McKeever3
1Department of Respiratory Care, King Faisal University, Al-Ahasa, Saudi Arabia.
Thorax
|June 19, 2023
概括
抗抑郁药的使用增加了慢性阻塞性肺病患者肺炎和COPD恶化的风险. 当治疗停止时,这些风险会降低,建议仔细监测和替代疗法.
科学领域:
- 肺部医学 肺部医学
- 药理学 药理学是指药理学的学科.
- 流行病学 流行病学
背景情况:
- 慢性阻塞性肺病 (COPD) 是一个主要的全球健康问题.
- 抗抑郁药通常被处方,但它们对呼吸系统疾病的影响需要进一步调查.
研究的目的:
- 为了确定抗抑郁药的处方是否与肺炎和COPD恶化的风险更高有关.
- 评估COPD患者抗抑郁药使用与呼吸系统事件之间的关联.
主要方法:
- 使用英国电子健康记录,采用了自我控制的病例系列设计.
- 对患有COPD且至少有一种抗抑郁药处方的患者进行了肺炎和COPD恶化事件分析.
主要成果:
- 抗抑郁药的使用与肺炎的风险增加79%和COPD恶化的风险增加16%在处方后90天内.
- 这些风险在停止服用抗抑郁药时减少.
- 即使在最初的90天后,也观察到COPD恶化的持续,略有增加的风险.
结论:
- 抗抑郁药与COPD患者肺炎和COPD恶化的风险增加有关.
- 建议对副作用进行监测,并考虑非药物干预措施.
- 这些发现强调了评估慢性呼吸系统疾病患者药物安全性的重要性.
更多相关视频
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
839
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
398
相关概念视频
Pneumonia II: Pathophysiology
365
The pathophysiology of pneumonia involves the following steps:
365
COPD: Management Using Bronchodilators and Corticosteroids
255
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
255
Pneumonia I: Introduction
285
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
285
Pneumonia IV: Management
399
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
399
Pneumonia III: Complications and Assessment
281
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
281
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
